Summary：Nasdaq’s Former Stars Stumble, Leaving Investors Feeling Uneasy **Introduction** The Nasdaq‑100 in

referrerpolicy="no-referrer"
style="max-width:100%;height:auto;display:block;margin:0 auto;">

Nasdaq’s Former Stars Stumble, Leaving Investors Feeling Uneasy

**Introduction**
The Nasdaq‑100 index has managed to stay relatively steady despite a noticeable wobble among its once‑dominant constituents. After a blistering first‑half rally that saw the top ten performers gain more than 200 % on a median basis, many of those same names are now losing momentum. Investors who rode the wave are questioning whether the rally was a flash in the pan or the start of a broader correction.

**Key Developments**
From March 30 to June 25, the ten best‑performing stocks in the Nasdaq‑100—spanning semiconductor makers, cloud‑service providers, and biotech innovators—posted median gains exceeding 200 %, according to a Yahoo Finance review of AlphaSpace data. Since late June, however, several of those leaders have slipped 10‑15 % from their peaks. Names such as a leading AI chip designer and a high‑growth software firm have reported earnings that missed analyst expectations, while others face mounting regulatory scrutiny. Trading volumes have risen on down days, indicating that profit‑taking and risk‑aversion are gaining traction.

**Industry Analysis**
The slowdown reflects a confluence of sector‑specific pressures and macro‑economic headwinds. Semiconductor firms are contending with softer demand for consumer electronics and a lingering inventory overhang. Cloud providers, which benefited from pandemic‑era digital acceleration, are now seeing slower enterprise spending as companies reassess cloud budgets amid higher interest rates. Biotech stocks, buoyed by early‑stage trial successes,